eHealth financials
$0.7189−0.88%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $554.0M | $532.4M |
| Gross profit | $554.0M | $532.4M |
| Gross margin | 100.0% | 100.0% |
| Operating income | $66.5M | $23.6M |
| Net income | -$10.4M | -$35.0M |
| Net margin | −1.9% | −6.6% |
| Diluted EPS | $-0.34 | $-1.19 |
| EBITDA | $82.3M | $49.4M |
| Operating cash flow | -$25.3M | -$18.4M |
| Free cash flow | -$27.6M | -$20.5M |
| Diluted shares | 30.5M | 29.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $73.7M | $39.2M |
| Short-term investments | $3.5M | $43.0M |
| Total debt | $113.0M | $68.5M |
| Total assets | $1.26B | $1.16B |
| Total liabilities | $288.8M | $229.5M |
| Shareholders' equity | $591.6M | $588.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology